mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.08 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.08 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.09 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.09 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.09 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.09 |